beta-solamarine has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, A; Li, X; Lou, H; Sun, L; Yuan, H; Zhao, Y | 2 |
2 other study(ies) available for beta-solamarine and Di Guglielmo Disease
| Article | Year |
|---|---|
Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells.
Topics: Antineoplastic Agents, Phytogenic; Blister; Blotting, Western; Carcinoma, Squamous Cell; Cell Membrane; Cytoskeleton; Fluorescent Antibody Technique; Gene Expression; Humans; K562 Cells; KB Cells; L-Lactate Dehydrogenase; Leukemia, Erythroblastic, Acute; Multidrug Resistance-Associated Proteins; Solanaceous Alkaloids; Time Factors | 2011 |
A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells.
Topics: Antineoplastic Agents; bcl-2-Associated X Protein; Calcium; Caspases; Cathepsin B; Cell Survival; Gene Expression Regulation; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membranes; Permeability; Proto-Oncogene Proteins c-bcl-2; Solanaceous Alkaloids; Tumor Stem Cell Assay | 2010 |